FDA Approves Treatment for Deadly C. Difficile Infections :

The FDA on Wednesday approved Seres Therapeutics's pill for treating a type of bacterial infection, giving an easier and standardized option to patients who often have to rely on individual donors for fecal transplants.

Related Keywords

Bengaluru , Karnataka , India , United States , Joseph Thome , Raghav Mahobe , Shinjini Ganguli , Aditya Samal , Maju Samuel , Mark Breidenbach , Reuters , Seres Therapeutics Inc , Nestle , Switzerland Based Ferring Pharmaceutical , C Diff Infection , Clostridium Difficile Infection , Lostridium Difficile Associated Disease , C Diff Associated Disease , Microbiome , Microbiota , Fecal Transplantation , Stool Transplant , Ecal Bacteriotherapy , Fecal Microbiota Transplantation , Mt Faecal Transplant Transplantation Bacteriotherapy Microbiota , Bacteria , Acterial Infection , Transplantation ,